Abbreviation | Formula | Mass | Main Class | Sub Class |
---|---|---|---|---|
GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 | C54H100N2O18 | 1064.697119 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 | C56H104N2O18 | 1092.728419 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 | C58H108N2O18 | 1120.759719 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 | C60H112N2O18 | 1148.791019 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 | C62H114N2O18 | 1174.806669 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 | C62H116N2O18 | 1176.822320 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 | C64H118N2O18 | 1202.837970 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 | C64H120N2O18 | 1204.853620 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 | C60H110N2O23 | 1226.749944 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 | C62H114N2O23 | 1254.781245 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 34:1;O2 | C62H113N3O23 | 1267.776493 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 | C64H118N2O23 | 1282.812545 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 36:1;O2 | C64H117N3O23 | 1295.807793 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 | C66H122N2O23 | 1310.843845 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 38:1;O2 | C66H121N3O23 | 1323.839093 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 | C68H124N2O23 | 1336.859495 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 | C68H126N2O23 | 1338.875145 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 40:1;O2 | C68H125N3O23 | 1351.870393 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 | C70H128N2O23 | 1364.890795 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 | C70H130N2O23 | 1366.906445 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O27 | 1372.807855 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 42:2;O2 | C70H127N3O23 | 1377.886043 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 42:1;O2 | C70H129N3O23 | 1379.901693 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 | C66H120N2O28 | 1388.802770 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 | C68H124N2O27 | 1400.839155 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 44:2;O2 | C72H131N3O23 | 1405.917343 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3(GalNAcβ1-4)Galβ1-4Glcβ-Cer 44:1;O2 | C72H133N3O23 | 1407.932994 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 | C68H124N2O28 | 1416.834070 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 | C70H128N2O27 | 1428.870455 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 | C68H123N3O28 | 1429.829318 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 34:1;O2 | C68H123N3O28 | 1429.829318 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 34:1;O2 | C68H123N3O28 | 1429.829318 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 | C70H128N2O28 | 1444.865370 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 | C72H132N2O27 | 1456.901755 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 | C70H127N3O28 | 1457.860618 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 36:1;O2 | C70H127N3O28 | 1457.860618 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 36:1;O2 | C70H127N3O28 | 1457.860618 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 | C72H132N2O28 | 1472.896670 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 | C74H134N2O27 | 1482.917405 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 | C74H136N2O27 | 1484.933055 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 | C72H131N3O28 | 1485.891919 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 38:1;O2 | C72H131N3O28 | 1485.891919 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 38:1;O2 | C72H131N3O28 | 1485.891919 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:2;O2 | C74H134N2O28 | 1498.912320 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Galα1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 42:1;O2 | C74H136N2O28 | 1500.927970 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:2;O2 | C76H138N2O27 | 1510.948705 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
Fucα1-2Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 44:1;O2 | C76H140N2O27 | 1512.964355 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 | C74H135N3O28 | 1513.923219 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GalNAcβ1-4(Galβ1-4GlcNAcβ1-3)Galβ1-4Glcβ-Cer 40:1;O2 | C74H135N3O28 | 1513.923219 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |
GlcNAcβ1-3Galβ1-3GalNAcβ1-4Galβ1-4Glcβ-Cer 40:1;O2 | C74H135N3O28 | 1513.923219 | Neutral glycosphingolipids [SP05] | GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) [SP0503] |